University of Texas Medical Branch, Galveston, TX, USA.
University of Texas Medical Branch, Galveston, TX, USA.
EBioMedicine. 2021 Dec;74:103722. doi: 10.1016/j.ebiom.2021.103722. Epub 2021 Nov 25.
Numerous publications describe the clinical manifestations of post-acute sequelae of SARS-CoV-2 (PASC or "long COVID"), but they are difficult to integrate because of heterogeneous methods and the lack of a standard for denoting the many phenotypic manifestations. Patient-led studies are of particular importance for understanding the natural history of COVID-19, but integration is hampered because they often use different terms to describe the same symptom or condition. This significant disparity in patient versus clinical characterization motivated the proposed ontological approach to specifying manifestations, which will improve capture and integration of future long COVID studies.
The Human Phenotype Ontology (HPO) is a widely used standard for exchange and analysis of phenotypic abnormalities in human disease but has not yet been applied to the analysis of COVID-19.
We identified 303 articles published before April 29, 2021, curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms. We present layperson synonyms and definitions that can be used to link patient self-report questionnaires to standard medical terminology. Long COVID clinical manifestations are not assessed consistently across studies, and most manifestations have been reported with a wide range of synonyms by different authors. Across at least 10 cohorts, authors reported 31 unique clinical features corresponding to HPO terms; the most commonly reported feature was Fatigue (median 45.1%) and the least commonly reported was Nausea (median 3.9%), but the reported percentages varied widely between studies.
Translating long COVID manifestations into computable HPO terms will improve analysis, data capture, and classification of long COVID patients. If researchers, clinicians, and patients share a common language, then studies can be compared/pooled more effectively. Furthermore, mapping lay terminology to HPO will help patients assist clinicians and researchers in creating phenotypic characterizations that are computationally accessible, thereby improving the stratification, diagnosis, and treatment of long COVID.
U24TR002306; UL1TR001439; P30AG024832; GBMF4552; R01HG010067; UL1TR002535; K23HL128909; UL1TR002389; K99GM145411.
大量出版物描述了 SARS-CoV-2(后急性 COVID-19 后遗症或“长新冠”)的临床症状,但由于方法多样且缺乏表示多种表型表现的标准,这些描述难以整合。以患者为中心的研究对于了解 COVID-19 的自然史尤为重要,但由于它们经常使用不同的术语来描述相同的症状或状况,整合受到阻碍。这一患者与临床特征描述的显著差异促使我们提出了一种用于指定表现的本体论方法,这将提高对未来长新冠研究的捕捉和整合能力。
人类表型本体(HPO)是一种广泛用于交换和分析人类疾病表型异常的标准,但尚未应用于 COVID-19 的分析。
我们确定了 2021 年 4 月 29 日之前发表的 303 篇文章,对描述急性 COVID-19 后 3 周或更长时间的 81 个队列的临床症状的 59 篇相关文献进行了策展,并将 287 个独特的临床发现映射到 HPO 术语上。我们提供了通俗同义词和定义,可用于将患者自我报告问卷与标准医学术语联系起来。长新冠的临床表现在不同的研究中没有得到一致的评估,而且大多数表现都被不同的作者用广泛的同义词来报告。至少有 10 个队列的作者报告了 31 个对应 HPO 术语的独特临床特征;报告最多的特征是疲劳(中位数 45.1%),报告最少的特征是恶心(中位数 3.9%),但各研究报告的百分比差异很大。
将长新冠的表现转化为可计算的 HPO 术语将提高对长新冠患者的分析、数据采集和分类能力。如果研究人员、临床医生和患者使用共同的语言,那么研究就可以更有效地进行比较/汇总。此外,将通俗术语映射到 HPO 将帮助患者协助临床医生和研究人员进行可计算的表型特征描述,从而改善长新冠的分层、诊断和治疗。
U24TR002306;UL1TR001439;P30AG024832;GBMF4552;R01HG010067;UL1TR002535;K23HL128909;UL1TR002389;K99GM145411。